Navigation Links
Nano-devices hold promise for early-stage cancer detection

They are miniature labs that can be swallowed like a pill, injected through a catheter, or woven into fabric. Their function is to screen for, detect, and potentially treat, cancer and other diseases when they are still at a single-cell size in early development stages. They will also detect harmful pathogens in food and water.

Engineering researchers at McMaster University will be escalating efforts to develop these micro- and nanotechnology-based bio-sensors and imaging devices through the support of a recently announced $4.25 million grant from the Canada Foundation for Innovation (CFI).

"This research is opening up a new front in the battle against cancer and other diseases," said Jamal Deen, the lead applicant, professor of electrical and computer engineering and Canada Research Chair in Information Technology, McMaster University. "The technology zeros in on specific malignant cells at an early stage when treatment can be more effective and potential side effects minimized."

The funding is part of a $10.6 million initiative to expand existing nano-fabrication and integration facilities at McMaster to establish a world-class Micro- and Nano-Systems Laboratory for the development of miniaturized, low-cost and easy-to-use prototypes for imaging and sensing in healthcare and environmental applications.

"The imaging and sensing technologies being pursued would be non-invasive, removing the discomfort, expense, and risk associated with many screening procedures, such as a colonoscopy," said Qiyin Fang, assistant professor of engineering physics and Canada Research Chair in Biophotonics at McMaster. "It would therefore allow for large-scale screening for early disease detection."

The bio-sensors and imaging devices being explored are based on integrating dissimilar technologies such as DNA, semiconductors, nanowires and polymers into "smart systems" on a small chip. The resulting micro-labs could contain miniaturi
'"/>

Source:McMaster University


Page: 1 2 3

Related biology news :

1. Priming embryonic stem cells to fulfill their promise
2. Probing the promise and perils of nanoparticles
3. Polymers with copper show promise for implanted sensors
4. New drug shows promise as powerful anticancer agent
5. Test for early detection of prostate cancer shows promise
6. Confocal imaging promises early detection of skin cancer
7. Its electric: Cows show promise as powerplants
8. Unusual antibiotics show promise against deadly superbugs
9. Novel compounds show promise as safer, more potent insecticides
10. Compound from Chinese medicine shows promise in head and neck cancer
11. Discovery of T-cell traffic control boosts new drug promise

Post Your Comments:
(Date:12/1/2009)... Particularly in Alzheimer,s disease, nerve cell d...ew therapeutic options may possibly be derived fro...sm. These findings have been published in the curr...ence . Until only a few years ago, neurogenesis t...ed to be impossible in the adult brain. The textbo...
(Date:12/1/2009)... Yehezkel Ben-Ari, winner of the 2009 Inserm Grand...ed its commitment to paying tribute to outstanding...ts. By honouring talents, Inserm intends to,demon...lved in today,s biological, medical and,health re...and women who carry out and,drive this research e...
(Date:12/1/2009)... In a world first, a Monash University-led interna...ay to boost the output of the next generation of s...n collaboration with colleagues from the universit...d tandem dye-sensitised solar cells with a three-f...red with previously reported tandem dye-sensitised...
Breaking Biology News(10 mins):New source discovered for the generation of nerve cells in the brain 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3Innovation puts next-generation solar cells on the horizon 2STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 1STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 2STALLERGENES 3A Strong Sales Growth in 1st Half Year 3A up 12 25 Full Year Guidance Maintained 13049 3NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur Rising Stars Honorees 51801 1NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur Rising Stars Honorees 51801 2NEA Portfolio Companies Selected as Zero2IPO Venture 50 and China Entrepreneur Rising Stars Honorees 51801 3Gene Mutation Is Linked to Heart Muscle Disease 51799 1Gene Mutation Is Linked to Heart Muscle Disease 51799 2
...ities of fish loaded with omega-3 fatty acids may ...rding to a study led by the University of Pittsbur... Aug. 5 issue of the Journal of the American Coll...ET, today. The study also found that third- and fo...even higher levels of atherosclerosis, or hardenin...
...2 levels rise, methods to mitigate these increases...hed in the July-August 2008 issue of Soil Science... roles of soils as a C sink in different regions i...Agriculture and Rural Development (Canada), the Na...niversity of Buenos Aires (Argentina), and Univers...
...ed by researchers at The University of Texas Schoo...xamined alcohol abuse and dependence among Hispani...xpanded to Mexican males living along the U.S.-Mex...million grant from the National Institute on Alcoh... of Health (NIH). , Researchers will survey 1,500 ...
Other Biology News:Eating fish may explain very low levels of heart disease in Japan 2Soil's carbon storage capacity investigated 2Soil's carbon storage capacity investigated 3Survey of Hispanics and alcohol dependence 2
(Date:12/2/2009)... , QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ -...(the "Company"), a global biopharmaceutical compan... announced that the U.S. Food and Drug Administrat...he Company,s PI3K/Akt pathway inhibitor compound, ...ed/refractory multiple myeloma. Keryx Biopharmaceu...
(Date:12/1/2009)..., INCLINE VILLAGE, Nev., Dec. 1 /PRNewswire-Fir...I ) today announced revenue guidance for the fourt... $57 million, as compared with $69 million for the...r 2008 results was the first of two installment pa...ed in fourth quarter 2008 results was a one-time $...
(Date:12/1/2009)... , CAMBRIDGE, Mass., Dec. 1 /PRNewswire/...ogy industry and to promote its potential, a group...ion of the Synthetic Biology Industry Association ...e goal of the association is to provide a forum fo...the new industry, address its opportunities and it...
(Date:12/1/2009)... , SAN FRANCISCO, Dec. 1 The Bu...most half the value it lost in October. The Select...xcellent month for the general markets with the Do...value. The gains held firm in the final two tradin... sluggish Thanksgiving holiday shopping and Dubai,...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4
...success of any RNA interference , ... siRNA or siRNA , expression ve..., researchers use cationic lipo...gents to deliver these molecules into cultured mam...eagent and the conditions under which it , ...
...l MessageAmp II Kit now with , Cy Dyes incl... Amplify as little as 100 ng of input RNA in a si... Greater sensitivity due to higher yields of...red by MEGAscript, the best technology for in , ...h labeling efficiency yields consistently high per...
... , No more siRNA design and... complete in 1 day , ...ration, RNase , III digestion and siRNA... Silencing Experiments The , ...to induce targeted gene , silen...
Other Biology Technology:Choose the Right Transfection Agent for Your RNAi Experiment 2Choose the Right Transfection Agent for Your RNAi Experiment 3Choose the Right Transfection Agent for Your RNAi Experiment 4Choose the Right Transfection Agent for Your RNAi Experiment 5Choose the Right Transfection Agent for Your RNAi Experiment 6Choose the Right Transfection Agent for Your RNAi Experiment 7Better RNA Amplification 2Better RNA Amplification 3Better RNA Amplification 4Better RNA Amplification 5Avoid siRNA Design Altogether! 2Avoid siRNA Design Altogether! 3
Mouse Anti-Human Spastin Monoclonal Antibody, Unconjugated, Clone Sp 3G11/1 from Santa Cruz Biotechnology, Inc.
mCD-1 Multi-Probe Template Set from BD Biosciences Pharmingen
Custom Immunization from Proteintech Group, Inc.
Rat Anti-Mouse VCAM-1 / CD106 Monoclonal Antibody, Unconjugated, Clone 112702 from R&D Systems
Biology Products: